Diabetes weight-loss medication advances to final trials | The Jerusalem PostJerusalem Post/Health & WellnessNovo Nordisk’s experimental drug amycretin shows strong results in its mid-stage trial, helping type 2 diabetes patients lose up to…
Diabetes weight-loss medication advances to final trials
